March 29, 2004

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal


MultOil May Lower CHD Risk

MIGDAL HAEMEG, IsraelDailyconsumption of canola-based MultOil, from Enzymotec (www.enzymotec.com), may lower coronary heart disease risk (CHD) through atriple defense mechanism, according to the company. In a clinical animal studyconducted at the Technion-Israel Institute of Technology and the RAMBAM MedicalCenter in Haifa, Israel, mice (bred to mimic the human cardiovascular system)were fed MultOil for a three-month period; control mice were fedcanola oil. MultOil was seen to reduce CHD risk by fighting thethree major causes that increase the risk: it reduced total cholesterol andtriglyceride levels, reduced blood serum oxidation levels by 60 percent andprevented the formation of foam cells that plug the arteries, according to thecompany.

In other news, Enzymotec will launch a series of dietarysupplements based on the MultOil platform, focusing on the needsof people wanting to reduce their risk of cardiovascular disorders as well asprotecting the heart of people already suffering from cardiovascular diseases.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like